Abstract:Conventionally, immunity in humans has been classified as innate and adaptive, with the concept that only the latter type has an immunological memory/recall response against specific antigens or pathogens. Recently, a new concept of trained immunity (a.k.a. innate memory response) has emerged. According to this concept, innate immune cells can exhibit enhanced responsiveness to subsequent challenges, after initial stimulation with antigen/pathogen. Thus, trained immunity enables the innate immune cells to respond robustly and non-specifically through exposure or re-exposure to antigens/infections or vaccines, providing enhanced resistance to unrelated pathogens or reduced infection severity. For example, individuals vaccinated with BCG to protect against tuberculosis were also protected from malaria and SARS-CoV-2 infections. Epigenetic modifications such as histone acetylation and metabolic reprogramming (e.g. shift towards glycolysis) and their inter-linked regulations are the key factors underpinning the immune activation of trained cells. The integrated metabolic and epigenetic rewiring generates sufficient metabolic intermediates, which is crucial to meet the energy demand required to produce proinflammatory and antimicrobial responses by the trained cells. These factors also determine the efficacy and durability of trained immunity. Importantly, the signaling pathways and regulatory molecules of trained immunity can be harnessed as potential targets for developing novel intervention strategies, such as better vaccines and immunotherapies against infectious (e.g., sepsis) and non-infectious (e.g., cancer) diseases. However, aberrant inflammation caused by inappropriate onset of trained immunity can lead to severe autoimmune pathological consequences, (e.g., systemic sclerosis and granulomatosis). In this review, we provide an overview of conventional innate and adaptive immunity and summarize various mechanistic factors associated with the onset and regulation of trained immunity, focusing on immunologic, metabolic, and epigenetic changes in myeloid cells. This review underscores the transformative potential of trained immunity in immunology, paving the way for developing novel therapeutic strategies for various infectious and non-infectious diseases that leverage innate immune memory.

"Glycans in Trained Immunity: Educators of innate immune memory in homeostasis and disease"

Trained immunity: adaptation within innate immune mechanisms.

Trained immunity: General and emerging concepts

The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

The causes and consequences of trained immunity in myeloid cells

The Role of Glycosylation in Inflammatory Diseases

Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter

Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.

Defining trained immunity and its role in health and disease

Semantic Instance Segmentation for Autonomous Driving

Glycobiology simplified: diverse roles of glycan recognition in inflammation

The mechanisms and cross-protection of trained innate immunity

Potent induction of trained immunity by Saccharomyces cerevisiae β-glucans

Probiotics and Trained Immunity

Emerging glyco-based strategies to steer immune responses

The role of neutrophils in trained immunity

The Role of Cell Metabolism in Innate Immune Memory

Trained immunity and inflammation in rheumatic diseases

Trained Immunity as an Adaptive Branch of Innate Immunity

Trained immunity in atherosclerotic cardiovascular disease